Auflistung nach Autor "Paterakis, G."

Analysis of transferrin receptor-1 and-2 expression in B cell chronic lymphocytic leukemia (B-CLL)

Kollia, P.; Smilevska, T.; Stamatopoulos, K.; Tsompanakou, A.; Stavroyianni, N.; Samara, M.; Paterakis, G.; Douka, V.; Hatzidimitriou, A.; Tachynopoulou, V.; Fassas, A.; Anagnostopoulos, A. (2003)

ETV6/RUNX1-Postitive Childhood Acute Lymphoblastic Leukemia (ALL): Do Additional Aberrations Influence Treatment Response and Outcome?

Ampatzidou, M.; Papadhimitriou, S. I.; Paterakis, G.; Petrikkos, L.; Pavlidis, D.; Tsitsikas, K.; Papadakis, V.; Vassilopoulos, G.; Polychronopoulou, S. (2014)

FETAL HEMOGLOBIN MODULATION BY NOVEL ALKYLATING AGENTS IN HUMAN ERYTHROID CELLS; SYNERGISTIC EFFECTS WITH ESTABLISHED HBF-INDUCING AGENTS

Chiotoglou, I.; Samara, M.; Paterakis, G.; Likousi, S.; Iakovidou, Z.; Mioglou, E.; Mourelatos, D.; Marinou, I.; Liakos, P.; Kollia, P. (2009)

Molecular analysis of transferrin receptor mRNA expression in acute myeloid leukaemia

Kollia, P.; Stavroyianni, N.; Stamatopoulos, K.; Zoi, K.; Viniou, N.; Mantzourani, M.; Noguchi, C. T.; Paterakis, G.; Abazis, D.; Pangalos, C.; Loukopoulos, D.; Yataganas, X. (2001)

Transferrin receptor (TfR, CD71) is an integral membrane glycoprotein that mediates cellular uptake of iron. In most tissues, TfR expression is correlated positively with proliferation and regulated at the post-transcriptional ...

Molecular and cellular mechanisms for fetal hemoglobin induction by hydroxyurea in normal erythroid progenitors

Likousi, S.; Paterakis, G.; Koumbi, D.; Tserga, A.; Papadakis, M.; Kletsas, D.; Katelzini, M.; Fibach, E.; Merianou, V.; Kollia, P. (2004)

Transferrin receptor-1 and 2 expression in chronic lymphocytic leukemia

Smilevska, T.; Stamatopoulos, K.; Samara, M.; Belessi, C.; Tsompanakou, A.; Paterakis, G.; Stavroyianni, N.; Athanasiadou, I.; Chiotoglou, I.; Hadzidimitriou, A.; Athanasiadou, A.; Douka, V.; Saloum, R.; Laoutaris, N.; Anagnostopoulos, A.; Fassas, A.; Stathakis, N.; Kollia, P. (2006)

Transferrin receptor (TfR)-1 and 2 mRNA and CD71 (TfR1) expression was analyzed in 118 CLL patients. Ninety-five out of 109 analyzed cases expressed CD71, mostly at a high level; 60% of CD71 (+) cases were IGH-mutated. All ...